Quốc gia: Israel
Ngôn ngữ: Tiếng Anh
Nguồn: Ministry of Health
FLURALANER
INTERVET ( ISRAEL) LTD
CHEWABLE TABLETS
FLURALANER 1000 MG
PER OS
Required
INTERVET GESMBH, AUSTRIA
Dogs: For the treatment of tick and flea infestations in dogs. This veterinary medicinal product is a systemic insecticide and acaricide that provides:- Immediate and presistent flea (Ctenocephalides felis) killing activity for 12 weeks,- Immediate and persistent tick killing activity for 12 weeks for Ixodes ricinus, Dermacentor reticulatus and D. variabilis,- Immediate and presistent tick killing activity for 8 weeks for Rhipicephalus sanguineus.Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. The onset of effect is within 8 hours of attachment for fleas (C. felis) and 12 hours of attachment for ticks (I. ricinus). The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).For the treatment of demodicosis caused by Demodex canis.For the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation.
2021-04-30
VETERINARY PRODUCT USER LEAFLET The product is dispensed with a veterinarian’s prescription only For veterinary use only 1. NAME OF THE MEDICINAL PRODUCT: BRAVECTO 112.5 MG CHEWABLE TABLETS VETERINARY BRAVECTO 250 MG CHEWABLE TABLETS VETERINARY BRAVECTO 500 MG CHEWABLE TABLETS VETERINARY BRAVECTO 1000 MG CHEWABLE TABLETS VETERINARY BRAVECTO 1400 MG CHEWABLE TABLETS VETERINARY 2. COMPOSITION: Active substance: Each chewable tablet contains: PRODUCT FLURALANER (MG) BRAVECTO 112.5 MG CHEWABLE TABLETS VETERINARY – for very small dogs (2-4.5 kg) 112.5 BRAVECTO 250 MG CHEWABLE TABLETS VETERINARY – for small dogs (>4.5-10 kg) 250 BRAVECTO 500 MG CHEWABLE TABLETS VETERINARY – for medium-sized dogs (>10-20 kg) 500 BRAVECTO 1000 MG CHEWABLE TABLETS VETERINARY – for large dogs (>20-40 kg) 1,000 BRAVECTO 1400 MG CHEWABLE TABLETS VETERINARY – for very large dogs (>40-56 kg) 1,400 See list of excipients in section 13 - “Further Information”. 3. WHAT IS THE MEDICINAL PRODUCT INTENDED FOR: For the treatment of tick and flea infestations in dogs. This veterinary medicinal product is a systemic insecticide and acaricide that provides: - immediate and persistent flea (_Ctenocephalides felis_) killing activity for 12 weeks. - immediate and persistent killing activity for 12 weeks of ticks of types _Ixodes ricinus, Dermacentor _ _reticulatus, Dermacentor variabilis_. - immediate and persistent killing activity for 8 weeks of tick type _Rhipicephalus sanguineus_. Fleas and ticks should attach to the host and commence feeding in order to be exposed to the active substance. The onset of the effect of the product is within 8 hours of attachment of the fleas (_C. felis_) and within 12 hours of attachment of ticks (_I. ricinus_). The product can be used as part of a treatment and prevention strategy for flea allergy dermatitis (FAD). Therapeutic group: Ectoparasiticides for systemic use. 4. CONTRAINDICATIONS: Do not use in case of hypersensitivity to the active substance or to any of the excipients. 5. ADVERSE REACTIONS: Co Đọc toàn bộ tài liệu
1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Bravecto 112.5 mg Chewable Tablets Veterinary Bravecto 250 mg Chewable Tablets Veterinary Bravecto 500 mg Chewable Tablets Veterinary Bravecto 1000 mg Chewable Tablets Veterinary Bravecto 1400 mg Chewable Tablets Veterinary 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Each chewable tablet contains: BRAVECTO CHEWABLE TABLETS FLURALANER (MG) for very small dogs (2–4.5 kg) 112.5 for small dogs (>4.5–10 kg) 250 for medium-sized dogs (>10–20 kg) 500 for large dogs (>20–40 kg) 1,000 for very large dogs (>40–56 kg) 1,400 For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Chewable tablet. Light to dark brown tablet with a smooth or slightly rough surface and circular shape. Some marbling, speckles or both may be visible. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of tick and flea infestations in dogs. This veterinary medicinal product is a systemic insecticide and acaricide that provides: - immediate and persistent flea ( _Ctenocephalides felis_ ) killing activity for 12 weeks, - immediate and persistent tick killing activity for 12 weeks for _ Ixodes ricinus, Dermacentor _ _reticulatus _ and _ D. variabilis,_ - immediate and persistent tick killing activity for 8 weeks for _Rhipicephalus sanguineus_ . Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. The onset of effect is within 8 hours of attachment for fleas ( _C. felis_ ) and 12 hours of attachment for ticks ( _I. ricinus_ ). The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD). 2 For the treatment of demodicosis caused by _Demodex canis_ . For the treatment of sarcoptic mange ( _Sarcoptes scabiei_ var. _canis_ ) infestation. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 4.4 SPECIAL WARNINGS FOR EAC Đọc toàn bộ tài liệu